Altamira Therapeutics (CYTO) Short Interest Ratio & Short Volume → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free CYTO Stock Alerts $1.49 -0.07 (-4.49%) (As of 05/20/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Altamira Therapeutics Short Interest DataCurrent Short Interest145,200 sharesPrevious Short Interest86,700 sharesChange Vs. Previous Month+67.47%Dollar Volume Sold Short$227,964.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2024Outstanding Shares1,580,000 sharesFloat Size2,210,000 sharesShort Percent of Float6.57%Today's Trading Volume39,251 sharesAverage Trading Volume222,437 sharesToday's Volume Vs. Average18% Short Selling Altamira Therapeutics ? Sign up to receive the latest short interest report for Altamira Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCYTO Short Interest Over TimeCYTO Days to Cover Over TimeCYTO Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Altamira Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024145,200 shares $227,964.00 +67.5%6.6%0.1 $1.57 4/15/202486,700 shares $144,789.00 -80.5%3.9%0.1 $1.67 3/31/2024444,500 shares $920,115.00 +620.4%28.1%0.4 $2.07 3/15/202461,700 shares $106,741.00 +9.0%3.9%0.1 $1.73 2/29/202456,600 shares $106,408.00 -6.3%3.6%0.2 $1.88 2/15/202460,400 shares $112,948.00 -13.7%3.8%0.1 $1.87 Get the Latest News and Ratings for CYTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Altamira Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202470,000 shares $129,500.00 +75.9%N/A0.1 $1.85 1/15/202439,800 shares $107,858.00 -29.1%N/A0 $2.71 12/31/202356,100 shares $195,228.00 -68.0%N/A0.1 $3.48 12/15/2023175,400 shares $650,734.00 -69.3%N/A0.2 $3.71 11/30/2023570,500 shares $223,179.60 +10.9%N/A0 $0.39 11/15/2023514,300 shares $50,915.70 +181.5%N/A0.1 $0.10 10/31/2023182,700 shares $27,003.06 +43.5%N/A0.2 $0.15 10/15/2023127,300 shares $30,233.75 +5.5%N/A0.3 $0.24 9/30/2023120,700 shares $29,511.15 +88.3%N/A0.4 $0.24 9/15/202364,100 shares $16,986.50 +33.5%N/A0.2 $0.27 8/31/202348,000 shares $17,275.20 -77.2%N/A0.2 $0.36 8/15/2023210,600 shares $80,028.00 -67.4%N/A0.4 $0.38 7/31/2023646,300 shares $245,594.00 +69.8%N/A1.1 $0.38 7/15/2023380,600 shares $146,911.60 +319.2%N/A0.3 $0.39 6/30/202390,800 shares $58,202.80 -16.5%N/A0 $0.64 6/15/2023108,700 shares $90,221.00 -47.4%N/A0 $0.83 5/31/2023206,600 shares $171,478.00 +140.0%N/A0.1 $0.83 5/15/202386,100 shares $80,572.38 -9.9%N/A0 $0.94 4/30/202395,600 shares $91,776.00 -92.0%N/A0 $0.96 4/15/20231,200,000 shares $1.36 million +253.5%N/A0.7 $1.13 3/31/2023339,500 shares $434,560.00 +5.1%31.2%0.3 $1.28 3/15/2023323,100 shares $429,723.00 +1,240.7%29.6%0.6 $1.33 2/28/202324,100 shares $57,840.00 +61.7%2.2%0.1 $2.40 2/15/202314,900 shares $39,336.00 +86.3%1.3%0.4 $2.64 1/31/20238,000 shares $22,080.00 -57.5%0.7%0.2 $2.76 1/15/202318,800 shares $97,760.00 -49.9%1.7%0.2 $5.20 12/30/202237,500 shares $181,875.00 +73.6%3.4%0.3 $4.85 12/15/202221,600 shares $110,160.00 -18.5%2.1%0.2 $5.10 11/30/202226,500 shares $149,725.00 +16.7%2.6%0.3 $5.65 11/15/202222,700 shares $130,525.00 -76.7%2.2%0.2 $5.75 10/31/202297,400 shares $728,552.00 +435.2%9.7%1 $7.48 10/15/202218,200 shares $107,452.80 -95.1%0.1%0.2 $5.90 9/30/2022371,000 shares $107,552.90 +69.2%2.6%0.3 $0.29 9/15/2022219,300 shares $85,066.47 -57.5%1.5%0.2 $0.39The #1 Crypto for AI (Ad)We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. 8/31/2022516,300 shares $188,965.80 +17.0%3.5%0.4 $0.37 8/15/2022441,300 shares $216,237.00 -46.7%3.0%0.3 $0.49 7/31/2022828,600 shares $364,584.00 +115.8%5.7%0.7 $0.44 7/15/2022383,900 shares $180,586.56 -11.8%2.6%0.3 $0.47 6/30/2022435,400 shares $211,299.62 -1.9%3.0%0.4 $0.49 6/15/2022444,000 shares $251,259.60 +30.7%3.0%0.4 $0.57 5/31/2022339,800 shares $249,413.20 +181.1%2.4%0.3 $0.73 5/15/2022120,900 shares $90,191.40 -62.2%0.8%0.1 $0.75 4/30/2022320,100 shares $284,889.00 -55.4%2.2%0.3 $0.89 4/15/2022717,300 shares $738,819.00 +64.3%4.9%0.6 $1.03 3/31/2022436,500 shares $480,150.00 -60.0%3.0%0.9 $1.10 3/15/20221,090,000 shares $912,221.00 +3,952.0%7.5%1.1 $0.84 2/28/202226,900 shares $26,232.85 -53.5%0.4%0 $0.98 2/15/202257,900 shares $70,638.00 -66.4%0.9%0.1 $1.22 1/31/2022172,200 shares $223,860.00 -52.7%2.6%0 $1.30 1/15/2022363,800 shares $600,270.00 -72.2%5.4%0.1 $1.65 12/31/20211,310,000 shares $2.38 million +1,073.8%19.5%0.3 $1.82 12/15/2021111,600 shares $147,312.00 -75.3%1.7%0 $1.32 11/30/2021452,100 shares $800,217.00 +495.7%6.7%0.1 $1.77 11/15/202175,900 shares $182,160.00 +19.5%1.1%0 $2.40 10/29/202163,500 shares $104,140.00 +212.8%0.9%0.3 $1.64 10/15/202120,300 shares $37,961.00 -51.9%0.3%0 $1.87 9/30/202142,200 shares $84,822.00 -19.5%0.6%0.1 $2.01 9/15/202152,400 shares $118,948.00 -26.9%0.8%0.1 $2.27 8/31/202171,700 shares $193,590.00 -51.3%1.1%0.1 $2.70 8/13/2021147,200 shares $447,488.00 No Change2.2%0.1 $3.04 CYTO Short Interest - Frequently Asked Questions What is Altamira Therapeutics' current short interest? Short interest is the volume of Altamira Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 145,200 shares of CYTO short. 6.57% of Altamira Therapeutics' shares are currently sold short. Learn More on Altamira Therapeutics' current short interest. Which institutional investors are shorting Altamira Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Altamira Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Altamira Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.57% of Altamira Therapeutics' floating shares are currently sold short. Is Altamira Therapeutics' short interest increasing or decreasing? Altamira Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 145,200 shares, an increase of 67.5% from the previous total of 86,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Altamira Therapeutics' float size? Altamira Therapeutics currently has issued a total of 1,580,000 shares. Some of Altamira Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Altamira Therapeutics currently has a public float of 2,210,000 shares. How does Altamira Therapeutics' short interest compare to its competitors? 6.57% of Altamira Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Altamira Therapeutics: Avenue Therapeutics, Inc. (3.26%), Dermata Therapeutics, Inc. (1.28%), Salarius Pharmaceuticals, Inc. (1.65%), Sonoma Pharmaceuticals, Inc. (0.30%), Clearmind Medicine Inc. (5.51%), CNS Pharmaceuticals, Inc. (0.31%), Notable Labs, Ltd. (0.08%), Onconetix, Inc. (0.31%), Galmed Pharmaceuticals Ltd. (1.49%), 60 Degrees Pharmaceuticals, Inc. (1.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Altamira Therapeutics stock? Short selling CYTO is an investing strategy that aims to generate trading profit from Altamira Therapeutics as its price is falling. CYTO shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Altamira Therapeutics? A short squeeze for Altamira Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CYTO, which in turn drives the price of the stock up even further. How often is Altamira Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYTO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Avenue Therapeutics Short Interest Dermata Therapeutics Short Interest Salarius Pharmaceuticals Short Interest Sonoma Pharmaceuticals Short Interest Clearmind Medicine Short Interest CNS Pharmaceuticals Short Interest Notable Labs Short Interest Onconetix Short Interest Galmed Pharmaceuticals Short Interest 60 Degrees Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CYTO) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss Ratings